{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001604191","name":"GridAI Technologies Corp.","summary":"Entero Therapeutics, Inc. (formerly First Wave Biopharma, Inc.) is a clinical-stage biopharmaceutical company focused on non-systemic therapies for gastrointestinal diseases. Its primary candidate is Adrulipase, a recombinant lipase enzyme derived from Yarrowia lipolytica, targeting exocrine pancreatic insufficiency in cystic fibrosis and chronic pancreatitis patients. Prior programs including Latiglutenase, Capeserod, and Niclosamide have been discontinued. The company completed and subsequently rescinded a merger with ImmunogenX, Inc.","people":[],"products":[{"name":"Adrulipase","type":"platform","description":"Recombinant lipase enzyme from Yarrowia lipolytica for treating exocrine pancreatic insufficiency in cystic fibrosis and chronic pancreatitis patients."},{"name":"Latiglutenase","type":"platform","description":"Oral biotherapeutic designed to break down gluten into non-immunogenic peptides for celiac disease; discontinued and subject to disposition."},{"name":"Capeserod","type":"platform","description":"Selective 5-HT4 receptor partial agonist in-licensed from Sanofi for gastroparesis; license terminated February 2025."},{"name":"Niclosamide","type":"platform","description":"Oral small molecule with anti-inflammatory properties for inflammatory bowel diseases including ulcerative colitis and Crohn's disease; discontinued."},{"name":"CypCel","type":"platform","description":"Metabolic marker compound measuring small-intestinal recovery in celiac patients on gluten-free diets; acquired via ImmunogenX merger, subject to disposition."}],"partnerships":[{"partner_name":"Sanofi","partnership_type":"licensing","description":"In-licensed Capeserod from Sanofi in September 2023; termination notice given February 26, 2025, effective April 2025.","start_date":null},{"partner_name":"Laboratoires Mayoly Spindler SAS","partnership_type":"licensing","description":"Originally sublicensed Adrulipase rights; company purchased all rights from Mayoly in March 2019, with Mayoly retaining exclusive commercial rights in France and Russia.","start_date":null},{"partner_name":"ImmunogenX, Inc.","partnership_type":"development","description":"Merged with IMGX in March 2024; rescission agreement announced March 2025 to unwind the merger by June 30, 2025.","start_date":null},{"partner_name":"Data Vault Holdings, Inc.","partnership_type":"licensing","description":"Announced binding letter of intent in September 2024 to exclusively license two technology product suites; transaction not expected to move forward.","start_date":null}],"affiliations":[],"origin":{"leaf":"b5bc64b86e5402b2f5a99f8617d91596a1cedd82497b0ffc6e871dfd1f1822ff","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"d065cc8781ab227e4c77a288a86d631d4726927a4ac0cef40e6303a8b1e1cebe","parent":"c1c5128635ed5b46676ac7355383017bba1859a500a373a9a0424a03316751fc","source":"0001410578-25-000618","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":69,"hourly_limit":500,"remaining":431,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}